Ceftaroline Fosamil Acetate

醋酸头孢洛林酯

Report date: 2022/03/07 17:57:48
NME

Base Information

Drug NameCeftaroline Fosamil Acetate
Drug Alias Name头孢罗林酯ceftarolina fosamilo头孢他若琳ceftarolinum fosamilum头孢洛林酯 +[14] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibioticsSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionCell wall inhibitorsBacterial penicillin-binding protein inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsComplicated Skin and Soft Tissue InfectionsCommunity Acquired PneumoniaCommunity-acquired bacterial pneumonia +[15] 
Global Approved IndicationsComplicated Skin and Soft Tissue InfectionsCommunity Acquired PneumoniaAcute bacterial skin and skin structure infections +[7] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2010/10/29
Country/TerritoryCzechiaBelgiumBulgaria +[43] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPending
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPfizer Ireland Pharmaceuticals LtdAllergan Plc
Inactive CompaniesAstrazeneca Pharmaceutical Co LtdFacta Farmaceutici SpaAstrazeneca Uk Ltd +[5] 
Active IndicationsComplicated Skin and Soft Tissue InfectionsCommunity Acquired PneumoniaAcute bacterial skin and skin structure infections +[7] 
Inactive IndicationsCommunity-acquired bacterial pneumoniaDrug-Related Side Effects and Adverse ReactionsKidney Diseases +[8] 

Other Information

ATC CodeJ01DI02
Related LinksWikipediaDrugBankKEGG